Alcon Gross Profit 2019-2024 | ALC

Alcon annual/quarterly gross profit history and growth rate from 2019 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Alcon gross profit for the quarter ending March 31, 2024 was $1.382B, a 5.9% increase year-over-year.
  • Alcon gross profit for the twelve months ending March 31, 2024 was $5.324B, a 9.89% increase year-over-year.
  • Alcon annual gross profit for 2023 was $5.247B, a 10.51% increase from 2022.
  • Alcon annual gross profit for 2022 was $4.748B, a 2.06% increase from 2021.
  • Alcon annual gross profit for 2021 was $4.652B, a 58.23% increase from 2020.
Alcon Annual Gross Profit
(Millions of US $)
2023 $5,247
2022 $4,748
2021 $4,652
2020 $2,940
2019 $3,662
2018 $3,192
Alcon Quarterly Gross Profit
(Millions of US $)
2024-03-31 $1,382
2023-12-31 $1,290
2023-09-30 $1,289
2023-06-30 $1,363
2023-03-31 $1,305
2022-12-31 $1,170
2022-09-30 $1,166
2022-06-30 $1,204
2022-03-31 $1,208
2021-12-31 $1,206
2021-09-30 $1,195
2021-06-30 $1,220
2021-03-31 $1,031
2020-12-31 $875
2020-09-30 $848
2020-06-30 $345
2020-03-31 $872
2019-12-31 $913
2019-09-30 $950
2019-06-30 $947
2019-03-31 $852
2018-12-31
2018-09-30 $568
2018-06-30 $878
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.738B $9.455B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.258B 27.30
Intuitive Surgical (ISRG) United States $142.628B 85.92
Edwards Lifesciences (EW) United States $54.439B 35.43
DexCom (DXCM) United States $52.033B 78.82
IDEXX Laboratories (IDXX) United States $42.817B 50.19
IQVIA Holdings (IQV) United States $41.793B 24.25
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.860B 30.66
SONOVA HOLDING (SONVY) Switzerland $18.415B 0.00
Hologic (HOLX) United States $17.398B 19.47
Fresenius Medical Care AG KGaA (FMS) Germany $12.570B 14.67
ShockWave Medical (SWAV) United States $12.376B 77.02
Sysmex ADR (SSMXY) Japan $10.888B 34.15
Teleflex (TFX) United States $10.032B 15.61
Globus Medical (GMED) United States $9.002B 26.39
Penumbra (PEN) United States $7.762B 88.21
Masimo (MASI) United States $6.610B 38.08
Glaukos (GKOS) United States $5.466B 0.00
TransMedics (TMDX) United States $4.559B 432.56
Integer Holdings (ITGR) United States $4.064B 24.56
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.279B 19.47
Tandem Diabetes Care (TNDM) United States $3.186B 0.00
Elekta AB (EKTAY) Sweden $3.019B 20.71
Inari Medical (NARI) United States $2.658B 0.00
Nihon Kohden (NHNKY) Japan $2.488B 21.05
RxSight (RXST) United States $2.307B 0.00
Integra LifeSciences Holdings (IART) United States $2.158B 9.41
Veracyte (VCYT) United States $1.665B 0.00
Alphatec Holdings (ATEC) United States $1.494B 0.00
Artivion (AORT) United States $0.978B 93.84
AVANOS MEDICAL, INC (AVNS) United States $0.931B 18.12
OPKO Health (OPK) United States $0.906B 0.00
Silk Road Medical (SILK) United States $0.869B 0.00
OrthoPediatrics (KIDS) United States $0.785B 0.00
Mesa Laboratories (MLAB) United States $0.639B 21.70
Paragon 28 (FNA) United States $0.620B 0.00
SiBone (SIBN) United States $0.579B 0.00
IRadimed (IRMD) United States $0.559B 31.28
ORTHOFIX MEDICAL INC (OFIX) United States $0.543B 0.00
Pulse Biosciences (PLSE) United States $0.537B 0.00
Pacific Biosciences Of California (PACB) United States $0.498B 0.00
Nevro (NVRO) United States $0.366B 0.00
Treace Medical Concepts (TMCI) United States $0.308B 0.00
Tactile Systems Technology (TCMD) United States $0.305B 10.44
Sight Sciences (SGHT) United States $0.272B 0.00
AxoGen (AXGN) United States $0.266B 0.00
AngioDynamics (ANGO) United States $0.235B 0.00
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.225B 0.00
908 Devices (MASS) United States $0.223B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Atossa Genetics (ATOS) United States $0.205B 0.00
Inogen (INGN) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.166B 8.44
Accuray (ARAY) United States $0.151B 0.00
Spectral Diagnostics (EDTXF) Canada $0.103B 0.00
Yubo Biotech (YBGJ) China $0.100B 0.00
KORU Medical Systems (KRMD) United States $0.097B 0.00
Sensus Healthcare (SRTS) United States $0.097B 20.48
Neuronetics (STIM) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Envoy Medical (COCH) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.058B 0.00
DarioHealth (DRIO) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.052B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
LENSAR (LNSR) United States $0.046B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Autonomix Medical (AMIX) United States $0.042B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.030B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Accelerate Diagnostics (AXDX) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.023B 0.00
QT Imaging Holdings (QTI) United States $0.020B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00